Annual Current Liabilities:
$80.61M+$43.68M(+118.25%)Summary
- As of today, TARS annual current liabilities is $80.61 million, with the most recent change of +$43.68 million (+118.25%) on December 31, 2024.
- During the last 3 years, TARS annual current liabilities has risen by +$69.13 million (+602.32%).
- TARS annual current liabilities is now at all-time high.
Performance
TARS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$90.25M+$3.94M(+4.57%)Summary
- As of today, TARS quarterly current liabilities is $90.25 million, with the most recent change of +$3.94 million (+4.57%) on June 30, 2025.
- Over the past year, TARS quarterly current liabilities has increased by +$38.68 million (+75.01%).
- TARS quarterly current liabilities is now at all-time high.
Performance
TARS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TARS Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | +118.3% | +75.0% |
3Y3 Years | +602.3% | +670.2% |
5Y5 Years | +9742.7% | +2835.1% |
TARS Current Liabilities Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | at high | +602.3% | at high | +580.9% |
5Y | 5-Year | at high | +9742.7% | at high | +1575.4% |
All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
TARS Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $90.25M(+4.6%) |
Mar 2025 | - | $86.31M(+7.1%) |
Dec 2024 | $80.61M(+118.2%) | $80.61M(+22.4%) |
Sep 2024 | - | $65.87M(+27.7%) |
Jun 2024 | - | $51.57M(+21.3%) |
Mar 2024 | - | $42.53M(+15.1%) |
Dec 2023 | $36.94M(+139.4%) | $36.94M(+58.9%) |
Sep 2023 | - | $23.25M(+57.5%) |
Jun 2023 | - | $14.77M(+11.4%) |
Mar 2023 | - | $13.26M(-14.1%) |
Dec 2022 | $15.43M | $15.43M(+8.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $14.27M(+21.8%) |
Jun 2022 | - | $11.72M(-7.1%) |
Mar 2022 | - | $12.61M(+9.9%) |
Dec 2021 | $11.48M(+113.1%) | $11.48M(+10.7%) |
Sep 2021 | - | $10.37M(-0.9%) |
Jun 2021 | - | $10.46M(+3.3%) |
Mar 2021 | - | $10.12M(+87.8%) |
Dec 2020 | $5.39M(+557.8%) | $5.39M(-12.3%) |
Sep 2020 | - | $6.14M(+99.8%) |
Jun 2020 | - | $3.08M(+275.5%) |
Dec 2019 | $819.00K(+357.5%) | $819.00K |
Dec 2018 | $179.00K | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual current liabilities?
- What is the all-time high annual current liabilities for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual current liabilities year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly current liabilities?
- What is the all-time high quarterly current liabilities for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual current liabilities?
The current annual current liabilities of TARS is $80.61M
What is the all-time high annual current liabilities for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual current liabilities is $80.61M
What is Tarsus Pharmaceuticals, Inc. annual current liabilities year-on-year change?
Over the past year, TARS annual current liabilities has changed by +$43.68M (+118.25%)
What is Tarsus Pharmaceuticals, Inc. quarterly current liabilities?
The current quarterly current liabilities of TARS is $90.25M
What is the all-time high quarterly current liabilities for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly current liabilities is $90.25M
What is Tarsus Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?
Over the past year, TARS quarterly current liabilities has changed by +$38.68M (+75.01%)